CVS Health Corp. (NYSE: CVS) Stock Competitors & Peer Comparison
See CVS's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CVS and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CVS | $97.23 | -0.38% | 124.1B | 12.40 | $7.84 | +2.73% |
| UNH | $399.66 | +0.85% | 362.9B | 21.44 | $18.64 | +2.24% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $405.84 | +0.69% | 88B | 13.80 | $29.39 | +1.69% |
| CI | $282.84 | -0.08% | 74.7B | 9.15 | $30.90 | +2.19% |
| HUM | $400.97 | +1.54% | 48.2B | 25.29 | $15.86 | +0.87% |
| CNC | $67.34 | +3.23% | 33.3B | 26.73 | $2.52 | N/A |
| MOH | $202.62 | -0.22% | 10.6B | 29.28 | $6.92 | N/A |
| OSCR | $30.33 | +1.69% | 7.9B | 21.66 | $1.40 | N/A |
| ALHC | $13.59 | +0.00% | 2.8B | 71.53 | $0.19 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
CVS vs UNH Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, UNH has a market cap of 362.9B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while UNH trades at $399.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas UNH's P/E ratio is 21.44. In terms of profitability, CVS's ROE is +0.06%, compared to UNH's ROE of +0.14%. Regarding short-term risk, CVS is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for CVS.Check UNH's competition here
Elevance Health Inc. (NYSE: ANTM)
CVS vs ANTM Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas ANTM's P/E ratio is 18.99. In terms of profitability, CVS's ROE is +0.06%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, CVS is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for CVS.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
CVS vs ELV Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, ELV has a market cap of 88B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while ELV trades at $405.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas ELV's P/E ratio is 13.80. In terms of profitability, CVS's ROE is +0.06%, compared to ELV's ROE of +0.11%. Regarding short-term risk, CVS is more volatile compared to ELV. This indicates higher risk in terms of short-term price fluctuations for CVS.Check ELV's competition here
Cigna Corporation (NYSE: CI)
CVS vs CI Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, CI has a market cap of 74.7B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while CI trades at $282.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas CI's P/E ratio is 9.15. In terms of profitability, CVS's ROE is +0.06%, compared to CI's ROE of +0.15%. Regarding short-term risk, CVS is less volatile compared to CI. This indicates lower risk in terms of short-term price fluctuations for CVS.Check CI's competition here
Humana Inc. (NYSE: HUM)
CVS vs HUM Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, HUM has a market cap of 48.2B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while HUM trades at $400.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas HUM's P/E ratio is 25.29. In terms of profitability, CVS's ROE is +0.06%, compared to HUM's ROE of +0.07%. Regarding short-term risk, CVS is less volatile compared to HUM. This indicates lower risk in terms of short-term price fluctuations for CVS.Check HUM's competition here
Centene Corp. (NYSE: CNC)
CVS vs CNC Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, CNC has a market cap of 33.3B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while CNC trades at $67.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas CNC's P/E ratio is 26.73. In terms of profitability, CVS's ROE is +0.06%, compared to CNC's ROE of -0.24%. Regarding short-term risk, CVS is less volatile compared to CNC. This indicates lower risk in terms of short-term price fluctuations for CVS.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
CVS vs MOH Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, MOH has a market cap of 10.6B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while MOH trades at $202.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas MOH's P/E ratio is 29.28. In terms of profitability, CVS's ROE is +0.06%, compared to MOH's ROE of -0.00%. Regarding short-term risk, CVS is less volatile compared to MOH. This indicates lower risk in terms of short-term price fluctuations for CVS.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
CVS vs OSCR Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, OSCR has a market cap of 7.9B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while OSCR trades at $30.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas OSCR's P/E ratio is 21.66. In terms of profitability, CVS's ROE is +0.06%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, CVS is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for CVS.Check OSCR's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
CVS vs ALHC Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, ALHC has a market cap of 2.8B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while ALHC trades at $13.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas ALHC's P/E ratio is 71.53. In terms of profitability, CVS's ROE is +0.06%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, CVS is less volatile compared to ALHC. This indicates lower risk in terms of short-term price fluctuations for CVS.Check ALHC's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
CVS vs CLOV Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, CLOV has a market cap of 2.2B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while CLOV trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas CLOV's P/E ratio is 100.84. In terms of profitability, CVS's ROE is +0.06%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, CVS is less volatile compared to CLOV. This indicates lower risk in terms of short-term price fluctuations for CVS.Check CLOV's competition here
Progyny, Inc. (NASDAQ: PGNY)
CVS vs PGNY Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, PGNY has a market cap of 2.1B. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while PGNY trades at $26.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas PGNY's P/E ratio is 27.10. In terms of profitability, CVS's ROE is +0.06%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, CVS is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for CVS.Check PGNY's competition here
Bright Health Group, Inc. (NYSE: BHG)
CVS vs BHG Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas BHG's P/E ratio is -0.12. In terms of profitability, CVS's ROE is +0.06%, compared to BHG's ROE of +0.04%. Regarding short-term risk, CVS is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for CVS.Check BHG's competition here
Universal American Corporation (NYSE: UAM)
CVS vs UAM Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, UAM has a market cap of 0. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas UAM's P/E ratio is 1.01. In terms of profitability, CVS's ROE is +0.06%, compared to UAM's ROE of +0.17%. Regarding short-term risk, CVS is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for CVS.Check UAM's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
CVS vs MGLN Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas MGLN's P/E ratio is 8.49. In terms of profitability, CVS's ROE is +0.06%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, CVS is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for CVS.Check MGLN's competition here
Triple-S Management Corporation (NYSE: GTS)
CVS vs GTS Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, GTS has a market cap of 0. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas GTS's P/E ratio is 10.41. In terms of profitability, CVS's ROE is +0.06%, compared to GTS's ROE of +0.07%. Regarding short-term risk, CVS is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for CVS.Check GTS's competition here
Aetna Inc. (NYSE: AET)
CVS vs AET Comparison September 2026
CVS Health Corp. (NYSE: CVS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CVS stands at 124.1B. In comparison, AET has a market cap of 0. Regarding current trading prices, CVS is priced at $97.23 on the NYSE, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CVS currently has a P/E ratio of 12.40, whereas AET's P/E ratio is 9.57. In terms of profitability, CVS's ROE is +0.06%, compared to AET's ROE of +0.11%. Regarding short-term risk, CVS is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for CVS.Check AET's competition here